Health Economics and Outcomes Research (HEOR) plays an essential role in assessing the value of healthcare interventions by analyzing their costs, clinical effectiveness, and impact on quality of life. HEOR researchers leverage a variety of real-world data sources, including electronic health records (EHR), claims data, and mortality data, to draw comprehensive insights about healthcare practices and policies. These insights are crucial for making informed decisions that enhance patient outcomes and optimize healthcare spending. Historically, researchers have often been confined to analyzing data sources in isolation, which significantly limits their ability to capture the full patient journey and understand the interdependencies of various health interventions and outcomes.
The ability to link data sources, across an ecosystem such as Datavant’s, offers researchers unparalleled opportunities to extract valuable, multifaceted insights from disparate data sets. As HEOR relies on diverse data sources to form its analyses, the challenge of maintaining patient confidentiality while merging these sources becomes significant. This is where tokenization comes into play. Tokenization is a data security method that replaces sensitive data elements with non-sensitive equivalents, known as tokens, which have no exploitable value. This process allows data linkage across different databases in a manner that preserves privacy, ensuring compliance with regulations like HIPAA in the United States.
One pivotal application of data linkage in HEOR is the integration of claims data with mortality data. Claims data provides detailed records of the healthcare services patients receive, while mortality data indicates patient death dates and causes. By linking these datasets, researchers can evaluate the long-term effectiveness and survival outcomes of treatments across various patient populations. This is especially crucial for assessing life-extending treatments in chronic diseases, where understanding the real-world effectiveness of healthcare interventions can directly influence clinical guidelines and patient care strategies.
Another significant use case involves the linkage of EHR, claims, and pharmacy data. This integration provides a holistic view of a patient's medical journey, offering insights into diagnosis, treatment patterns, medication adherence, and clinical outcomes. For instance, by analyzing linked data, researchers can identify discrepancies between prescribed medications and actual patient adherence, assess the impact of medication on patient outcomes, and detect potential drug interactions. Such analyses are invaluable for improving medication management protocols and enhancing patient safety and treatment effectiveness.
A third use case is the linkage of internal primary data, such as data from clinical trials, with claims data. This linkage can enrich the understanding of clinical trial cohorts by providing additional insights into patients' pre- and post-trial healthcare utilization and outcomes. For pharmaceutical companies and healthcare providers, understanding the broader impacts of a drug or treatment beyond the controlled trial setting into the real world can improve market strategies, patient monitoring programs, and post-market surveillance efforts.
The linkage of real-world data sources using privacy-preserving methods like tokenization is indispensable in HEOR. It enables researchers to conduct thorough, multidimensional analyses while safeguarding patient privacy. The ability to seamlessly integrate diverse datasets opens up new vistas for understanding drug effectiveness, treatment patterns, and health outcomes in real-world settings. As healthcare continues to evolve towards more data-driven decision-making, the strategic use of data linkage in HEOR will be critical in shaping future healthcare policies and practices that are both effective and economically viable.
Explore how Datavant can be your health data logistics partner.
Contact us